Emtricitabine Active Not Recruiting Phase 4 Trials for Pre-Exposure Prophylaxis / Transgender Persons Other

Indications	Status	Purpose	Phase
DBCOND0040540 (Pre-Exposure Prophylaxis) DBCOND0091777 (Transgender Persons)	Active Not Recruiting	Other	4

clinicaltrials.gov Identifier	Title	Drugs
NCT03120936	The Stay Study: A Demonstration Project Advancing PrEP Delivery in the San Francisco Bay Area Transgender Community	Emtricitabine (DB00879) Tenofovir disoproxil (DB00300)